Skip to main content
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
459.80
-9.40 (-2.00%)
At close: Apr 29, 2026

HKG:6990 Revenue

In the year 2025, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 2.06B CNY with 6.46% growth. Sichuan Kelun-Biotech Biopharmaceutical had revenue of 1.11B in the half year ending December 31, 2025, with 124.06% growth.

Revenue
2.06B CNY
Revenue Growth
+6.46%
P/S Ratio
46.82
Revenue / Employee
1.01M CNY
Employees
2,045
Market Cap
107.22B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.06B124.88M6.46%
Dec 31, 20241.93B392.55M25.48%
Dec 31, 20231.54B736.56M91.62%
Dec 31, 2022803.93M771.61M2,387.26%
Dec 31, 202132.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akeso 3.40B
Sino Biopharmaceutical 35.43B
WuXi Biologics 24.25B
Innovent Biologics 14.51B
RemeGen 3.62B
3SBio 19.69B
BeOne Medicines AG 41.59B
Biocytogen Pharmaceuticals (Beijing) 1.78B
Revenue Rankings

Sichuan Kelun-Biotech Biopharmaceutical News

More News